omeprazole has been researched along with sc 560 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, Y; Kubo, Y; Takeuchi, K; Tanaka, A | 1 |
| Takahira, Y; Takeuchi, K; Tanaka, A; Taniguchi, M; Yokota, A | 1 |
2 other study(ies) available for omeprazole and sc 560
| Article | Year |
|---|---|
Functional mechanism underlying COX-2 expression following administration of indomethacin in rat stomachs: importance of gastric hypermotility.
Topics: Animals; Atropine; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Enzyme Inhibitors; Gastric Acid; Gastric Mucosa; Gastrointestinal Hemorrhage; Gastrointestinal Motility; Indomethacin; Isoenzymes; Lactones; Male; Omeprazole; Peroxidase; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Sprague-Dawley; RNA, Messenger; Stomach; Stomach Ulcer; Sulfones | 2004 |
Dexamethasone damages the rat stomach but not small intestine during inhibition of COX-1.
Topics: Animals; Anti-Inflammatory Agents; Anti-Ulcer Agents; Atropine; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dexamethasone; Dinoprostone; Gastric Mucosa; Gastrointestinal Motility; Gene Expression; Intestinal Mucosa; Intestine, Small; Male; Muscarinic Antagonists; Nitric Oxide Synthase Type II; Omeprazole; Pyrazoles; Rats; Rats, Sprague-Dawley; Stomach | 2007 |